This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Beckman Research Institute, City of Hope, City of Hope. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lihua Elizabeth Budde: Innovator in Cancer Treatment
Introduction
Lihua Elizabeth Budde is a prominent inventor based in Duarte, California. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on targeted therapies that aim to improve patient outcomes in oncology.
Latest Patents
Lihua Elizabeth Budde holds a patent for her invention titled "CD33 Targeted Chimeric Antigen Receptor Modified T Cells for Treatment of CD33 Positive Malignancies." This patent represents a breakthrough in the treatment of specific types of cancer, showcasing her commitment to advancing medical science.
Career Highlights
Budde is affiliated with City of Hope, a leading research and treatment center. Her role at this esteemed institution allows her to collaborate with other experts in the field and contribute to groundbreaking research initiatives.
Collaborations
Throughout her career, Lihua has worked alongside notable colleagues, including David A. Horne and Tongyuan Xue. These collaborations have further enhanced her research and development efforts in cancer therapies.
Conclusion
Lihua Elizabeth Budde is a trailblazer in the field of cancer treatment, with her innovative patent and collaborative spirit driving advancements in medical science. Her work continues to inspire future innovations in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile